The medical additive manufacturing segment consists in medical devices, anatomical models, prosthetics and more. In the industry, bioprinting has a prominent position, gaining interest across the board for its huge potentials in drug development and screening, therapeutic treatments and regenerative medicine, and more. While much of the excitement surrounding bioprinting is what it could do in the future, let’s take a look of what is happening now in the field.
In a study published by a Media Organism of what’s happening in the sector to be considered the most exciting in Bioprinting, the company talked with Biogelx, a scottish company. The company is one of a handful that is developing and producing tunable synthetic materials for bioprinting applications. In the last year, Biogelx commercialized its first synthetic bioink product range for bioprinting.
Considering the materials-side, Biogelx sees inks with biologic origin as being a crucial factor in advancing bioprinting applications.
Here at Biogelx, we are particularly interested in the use of new bioink technologies for the creation of functional tissues,” (…), “These functional tissues have potential use in replacing injured or diseased tissue, or could provide a non-animal alternative for testing drugs and cosmetics.”
Within the spectrum of bioprinting materials, the Strathclyde-based company sees significant potential in hydrogel-based bioinks, because of their excellent biocompatibility and biodegradability. Hydrogel-based bioinks also offer the advantage of facilitating cell differentiation, spreading, growth and attachment.
“There is a great amount of interest in the development of new bioink formulations and materials, which will only increase as both the printer and bioink technologies are further developed,” (…), “With this, there will be an increased need for metrics to measure bioink performance, leading to more clearly defined standardisation in uses for bioinks. More and more uses for bioinks are emerging, and we believe the development of new bio-printable skin models will be an impactful demonstration of the power of bioprinting.”, commented the company.
Biogelx has been gaining space in the bioprinting market by creating partnerships around the world and expanding its reseller network. Nowadays, the company’s bioprinting materials are used for a handful of applications, including drug screening, where there is a need to create more physiologically relevant in vitro models.
Find More Additive Manufacturing Industry News
- Sources & More information
Related article categories:
Article and featured image:
Tess Boissoneault, 3D Printing Media Network Biogelx and the role of bioinks in bioprinting today https://www.3dprintingmedia.network/bioprinting-today-series-biogelx-bioinks/ published on Feb14 2020, re-edited and published on Feb24 2020;
Featured Image & Article Photo: